table_specific

What was the net income (loss) for Learningrx in 2022?

Learningrx Franchise · 2025 FDD

Answer from 2025 FDD Document

--------------------|------|---------|---|------|----------| | Net Income (Loss) | | 7,181 | - | | (55,041) | | Retained Earnings, End of Year | $ | 773,206 | _ | $ | 766,025 |

![](_page_76_Picture

Source: Item 23 — RECEIPT (FDD pages 54–209)

What This Means (2025 FDD)

According to Learningrx's 2025 Franchise Disclosure Document, the net income (loss) for the company in 2022 was a loss of $55,041. This figure is derived from the Learningrx Franchise Corporation Statements of Cash Flows, which provides a detailed breakdown of cash flow activities, including net income or loss.

This loss indicates that Learningrx's expenses exceeded its income during that period. For a prospective franchisee, this information is crucial as it provides insight into the financial health and stability of the company. A history of losses might suggest potential challenges in the business model or market conditions that could affect the franchisee's own profitability.

It's important to note that a single year's loss does not necessarily indicate long-term financial instability. However, a prospective Learningrx franchisee should investigate further, examining the company's financial statements over several years to identify trends and understand the reasons behind the loss. Understanding the context of this loss, such as any significant investments or one-time expenses incurred during 2022, is essential for making an informed decision about investing in a Learningrx franchise.

Furthermore, the FDD includes an Independent Auditor's Report, which states that the financial statements present fairly the financial position of Learningrx. This provides some assurance that the financial information is reliable and has been audited according to generally accepted accounting principles in the United States of America.

Disclaimer: This information is extracted from the 2025 Franchise Disclosure Document and is provided for research purposes only. It does not constitute legal or financial advice. Consult with a franchise attorney before making any investment decisions.